FDA Warning Letter, 483 observation, ANSM injunction or inspection report referencing data integrity or CSV/CSA: targeted, confidential support to structure your response.
Review of the observation received, identification of root causes and associated deviations.
Action plan, timeline, CAPAs drafted in the format expected by the authority.
Coaching for staff likely to interact with the inspector or authority.
This applies both to an observation explicitly about data integrity and to one concerning the validation status of your computerized systems (CSV/CSA).
Confidential initial conversation, no obligation.
Describe my situation